Intellia Therapeutics (NTLA) Prepaid Assets (2015 - 2026)

Intellia Therapeutics (NTLA) has reported Prepaid Assets for 12 consecutive years, with $81.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 118.98% year-over-year to $81.3 million; the TTM figure through Mar 2026 stood at $81.3 million (up 118.98% YoY), while the FY2025 annual figure was $68.4 million, up 129.15% from the prior year.
• Prepaid Assets rose to $81.3 million in Q1 2026 per NTLA's latest filing, from $68.4 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $81.3 million in Q1 2026 and bottomed at $18.3 million in Q2 2022.
• Historically, Prepaid Assets has averaged $39.6 million across 5 years, with a median of $32.2 million in 2023.
• Annual changes were most pronounced in 2023 — Prepaid Assets surged 143.3% — and 2025, when it tumbled 53.65%.
• Intellia Therapeutics' Prepaid Assets stood at $20.4 million in 2022, then surged by 143.3% to $49.7 million in 2023, then plunged by 39.92% to $29.8 million in 2024, then soared by 129.15% to $68.4 million in 2025, then gained by 18.98% to $81.3 million in 2026.
• Business Quant data shows NTLA's Prepaid Assets at $81.3 million in Q1 2026, $68.4 million in Q4 2025, and $59.8 million in Q3 2025.